MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumours and Leukemia
This is an open-label study which will permit subjects with solid tumours or leukemia, who
are currently clinically benefitting on another GSK sponsored trial with GSK1120212 either
monotherapy or in combination continued access to GSK1120212.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society